Skip to main content
    G

    GE HealthCare Technologies Inc. (GEHC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $82.96
    -0.06 (-0.07%)

    Market Cap: $37.54B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    GE HealthCare Technologies Inc. (GEHC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect GE HealthCare Technologies (GEHC) to earn $5.02 per share in the fiscal year ending Dec 31, 2026, on revenue of $21.86B. Of 22 analysts, 16 rate the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $5.50.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 22 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 73% of the ratings.

    RatingAnalystsShare
    Strong Buy627.3%
    Buy1045.5%
    Hold627.3%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    22

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 9.6% and revenue estimates rise 4.9%.

    Fiscal year ending Dec 31, 2026
    $5.02
    EPS consensus, revenue $21.86B
    Fiscal year ending Dec 31, 2027
    $5.50
    EPS consensus, revenue $22.93B
    Next report
    Feb 8, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$5.02$4.99 to $5.0622$21.86B$21.76B to $21.92B21
    Dec 31, 2027$5.50$5.09 to $5.7020$22.93B$22.68B to $23.18B18

    Quarterly Estimates

    The EPS consensus falls from $1.59 for the quarter ending Dec 31, 2026 to $1.11 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.59$1.50 to $1.6821$6.04B$5.71B to $6.28B20
    Mar 31, 2027$1.11$0.99 to $1.2512$5.37B$5.34B to $5.39B9

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 1.8% from $4.93.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$5.02$5.02$4.93$4.93$4.93+1.9%
    Fiscal year ending Dec 31, 2027$5.50$5.50$5.41$5.41$5.41+1.7%
    Quarter ending Mar 31, 2027$1.11$1.12$1.13$1.13$1.13-1.7%

    Frequently Asked Questions About GEHC

    What is the GEHC stock forecast?

    Consensus analyst estimates put GE HealthCare Technologies's EPS at $5.02 for the fiscal year ending Dec 31, 2026, on revenue of $21.86B. The consensus rating from 22 analysts is Buy.

    How do analysts rate GEHC stock?

    Of 22 analysts covering GE HealthCare Technologies, 6 rate it Strong Buy, 10 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from GEHC next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $5.02, with estimates from $4.99 to $5.06 from 22 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $5.50, with estimates from $5.09 to $5.70 from 20 analysts.

    What revenue do analysts expect from GE HealthCare Technologies next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $21.86B, with estimates from $21.76B to $21.92B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $22.93B, with estimates from $22.68B to $23.18B.

    How many analysts cover GEHC?

    22 analysts rate GE HealthCare Technologies stock, and 22 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.